Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg.
Nicola CapassoRaffaele PalladinoEmma MontellaFrancesca PenninoRoberta LanzilloAntonio CarotenutoMaria PetraccaRosa IodiceAniello IovinoFrancesco ArutaViviana PastoreAntonio Riccardo BuonomoEmanuela ZappuloGentile IvanMaria TriassiVincenzo Brescia MorraMarcello MocciaPublished in: Journal of clinical medicine (2020)
MS patients have similar risk of SARS-CoV-2 infection to the general population, and can be asymptomatic from COVID-19, also if using treatments with systemic immunosuppression.